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 RESULTS Oral administration of 0,3 g LF/day could not reduce the excretion 
of E. coli. Therefore, after 19 days of treatment, we raised the daily 
dose to 3 g LF/day. Subsequently, faecal shedding decreased in the 
LF group, although there was no significant difference between the 
LF group and the control group. This could be due to the low 
number of animals in each group. It has been shown that 
lactoferrin has an immunomodulating effect on the acquired 
immune system (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was no difference in the immunological response to EspA 
and EspB between the LF group and the control group, although 
the antibody response to intimin was diminishing more slowly in 
the LF group during the 0,3 g/day treatment. A high LF dose more 
clearly increased the EspA- and EspB specific IgG responses, while 
the intimin-specific IgG response was diminishing more slowly 
compared to the control group. IgA or IgM responses were not 
detected. 
 
 
 
 
 
 
 
 
 
DISCUSSION & CONCLUSIONS 
This and previous studies performed by our group, showed that  E. coli O157:H7 infected sheep have benefits from a  preventive and curative 
lactoferrin treatment. These  results all together suggest that lactoferrin could be  an interesting tool to decrease the colonization pressure at farm  
level and so prevent contamination of food by EHEC. 
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INTRODUCTION 
Enterohemorrhagic Escherichia coli (EHEC) are a major food-borne 
pathogen causing severe disease in humans worldwide [1]. The 
clinical spectrum of EHEC includes bloody or non-bloody diarrhea, 
haemorrhagic colitis (HC) and haemolytic uremic syndrome (HUS), 
the leading cause of chronic renal failure and mortality [2]. 
Furthermore, contamination with EHEC may have important 
economical consequences due to withdrawal of food from the 
marked and decreased export [3]. Ruminants, mainly cattle and to 
a lesser extent sheep,  are the most important reservoir of EHEC, 
harbouring the bacteria in the gastrointestinal tract without 
showing clinical symptoms. Various strategies have been tried to 
reduce the colonization of cattle, including vaccination, treatment 
with probiotics, administration of bacteriophages and modification 
of the diet. These strategies are too expensive, too labor intensive 
or show only limited effects [1]. In this project, the treatment of 
EHEC infected sheep with bovine lactoferrin (LF) was investigated. 
Lactoferrin is a transferrin protein with bacteriostatic and 
bactericidal effects on gram-negative bacteria by binding free iron, 
which is an essential growth factor for bacteria, and by destabilizing 
the outer membrane of gram-negative bacteria [4].  
 
MATERIAL AND METHODS 
Ten sheep were orally inoculated with 1010 CFU E. coli (strain 
NCTC12900) for 2 consecutive days. On day 4, the oral treatment of 
the LF-group (n=5) with 0,3 g/day was started for 19 days 
whereafter the dose was increased to 3 g/day for 14 days. The 
control group (n=5) received only the 10% sodium bicarbonate 
buffer. Faecal samples were collected 2 times a week during the 
infection and treatment period. The faecal excretion was monitored 
by direct plating and immunomagnetic separation, as a selective 
enrichment method for E. coli O157:H7. Blood samples were taken 
once a week to monitor the antibody response to virulence factors. 
 
 
 
 
Fig. 1 Average faecal excretion  of E. coli O157:H7 CFU/g faeces (log 10). Compared to the control group, 
excretion in the  LF group goes down decreases faster when administering 3g LF/day treatment. (not 
statistically significant)  
Fig 2. Average specific serumantibodyresponses against  EspB , EspA (B) and intimin (C) after infection of 
sheep  With E. coli O157:H7 with and without lactoferrin treatment.  Values are average log2 values + SD.  
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